Main outcomes and measures: The main outcome measure was facial nerve weakness.

The number of spasm events was not associated with facial nerve outcome.

The facial nerve dysfunctions caused by the therapy were evaluated and analyzed.

This study is a retrospective review of facial nerve dysfunction after sclerotherapy.

Patients: Patients included underwent resection of an intratemporal facial nerve mass.